journal article·2022-05-06Open access

The Effect of Probiotics on Intestinal Tight Junction Protein Expression in Animal Models: A Meta-Analysis

Sung-Il Ahn, Sangbuem Cho, Eunjeong Jeon, Myungsun Park, Byungho Chae, Isaac Celestin Poaty Ditengou, Nag-Jin Choi

Applied Sciences· Volume 12· Issue 9

Abstract

This study investigates the effect of probiotics supplementation on tight junction protein (TJP) expression in animal models by meta-analysis. We estimated the effect of probiotics administration in an animal inflammatory bowel disease model based on 47 collected articles from the databases, including Sciencedirect, Pubmed, Scopus, and Google Scholar. The effect size was analyzed with the standardized mean difference, and the heterogeneity of the effect sizes was assessed using Cochran’s Q test. To explain the heterogeneity, moderate analyses, such as meta-ANOVA and meta-regression, were performed using the mixed effects model. Finally, publication bias was assessed using Egger’s linear regression test. Among the evaluated items, zonula occluden (ZO)-1 showed the highest Q statistics value, and the effect sizes of all items were positive with high significance (p < 0.0001). The I2 value of all items reflected high heterogeneity (in excess of 80%). From the results of the meta-ANOVA, the factors of the heterogeneity found in the probiotics strains were investigated. Lactobacillus reuteri was identified as having the greatest effect on claudin and ZO-1 expression. The publication bias was detected by the Egger’s linear regression test, though it revealed that the occludin and ZO-1 had larger sample sizes than the claudin. In sum, this meta-analysis reveals that probiotics are effective at improving TJP expression in a gut environment of inflammatory bowel disease (IBD)-induced animal model. Our findings will interest IBD patients, as they suggest an area warranting future study.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Gut microbiota and health · Barrier Structure and Function Studies · Mycobacterium research and diagnosis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Animal Science, Jeonbuk National University, Jeonju 54896, Korea

Dairy Science Division, National Institute of Animal Science, Rural Development Administration, Cheonan 31000, Korea

Hanwoo Research Institute, National Institute of Animal Science (RDA), Pyeongchang 25340, Korea

Funding

National Research Foundation of Korea · Korean government (Ministry of Science and ICT)

References (90)

Show source-provided references
1. Expert consensus document. The International Scientific Association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic10.1038/nrgastro.2014.66 ↗
2. Prevention of inflammatory bowel disease using fermented milk including probiotics
3. Effect of dietary probiotics on colon length in an inflammatory bowel disease–induced murine model: A meta-analysis10.3168/jds.2019-17356 ↗
4. A randomised, double-blind, placebo-controlled trial of multi-strain probiotics in patients with asymptomatic ulcerative colitis and Crohn’s disease10.1007/s10787-019-00595-4 ↗
5. Effect of probiotics on pro-inflammatory cytokines and NF-κB activation in ulcerative colitis10.3748/wjg.v16.i33.4145 ↗
6. Probiotics (VSL#3) in arthralgia in patients with ulcerative colits and Crohn’s disease: A pilot study10.1358/dot.2005.41.7.917341 ↗
7. Ecological and evolutionary forces shaping microbial diversity in the human intestine10.1016/j.cell.2006.02.017 ↗
8. Microbes and health sackler colloquium: Epithelial crosstalk at the microbiota-mucosal interface10.1073/pnas.1000092107 ↗
9. Intestinal mucosal barrier function in health and disease10.1038/nri2653 ↗
10. Tight junction pore and leak pathways: A dynamic duo10.1146/annurev-physiol-012110-142150 ↗
11. The tight junction: A multifunctional complex10.1152/ajpcell.00558.2003 ↗
12. Cereijido, M., and Anderson, J.M. (2003). Tight Junctions, CRC Press.
13. Tight junctions in the skin10.1016/S0923-1811(03)00038-0 ↗
14. Occludin regulates macromolecule flux across the intestinal epithelial tight junction barrier10.1152/ajpgi.00055.2011 ↗
15. Intestinal permeability regulation by tight junction: Implication on inflammatory bowel diseases10.5217/ir.2015.13.1.11 ↗
16. ZO-3, a novel member of the MAGUK protein family found at the tight junction, interacts with ZO-1 and occludin10.1083/jcb.141.1.199 ↗
17. Establishment and characterization of cultured epithelial cells lacking expression of ZO-110.1074/jbc.M406563200 ↗
18. Regulation of tight junction permeability by intestinal bacteria and dietary components10.3945/jn.110.135657 ↗
19. Effect of intestinal tight junction protein expression on growth performance for eco-friendly broiler production: Meta-analysis
20. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews10.1136/bmj.n71 ↗
21. Kmet, L.M., Lee, R.C., and Cook, L.S. (2004). Standard Quality Assessment Criteria for Evaluating Primary Research Papers from a Variety of Fields, Health Technology Assessement Unit, Alberta Heritage Foundation for Medical Research.
22. Phan, H.L., Le, T.H., Lim, J.M., Hwang, C.H., and Koo, K.I. (2022). Effectiveness of augmented reality in stroke rehabilitation: A Meta-Analysis. Appl. Sci., 12.10.3390/app12041848 ↗
23. Probiotic mixtures with aerobic constituent promoted the recovery of multibarriers in DSS-induced chronic colitis10.1016/j.lfs.2019.117089 ↗
24. Lactobacillus rhamnosus alleviates intestinal barrier dysfunction in part by increasing expression of zonula occludens-1 and myosin light-chain kinase in vivo10.3168/jds.2008-1698 ↗
25. Clostridium butyricum modulates the microbiome to protect intestinal barrier function in mice with antibiotic-induced dysbiosis10.1016/j.isci.2019.100772 ↗
26. Bifidobacterium breve ATCC15700 pretreatment prevents alcoholic liver disease through modulating gut microbiota in mice exposed to chronic alcohol intake10.1016/j.jff.2020.104045 ↗
27. Live and heat-killed cells of Lactobacillus plantarum Zhang-LL ease symptoms of chronic ulcerative colitis induced by dextran sulfate sodium in rats10.1016/j.jff.2020.103994 ↗
28. Lactobacillus rhamnosus GG supernatant promotes intestinal barrier function, balances Treg and TH17 cells and ameliorates hepatic injury in a mouse model of chronic-binge alcohol feeding10.1016/j.toxlet.2015.11.019 ↗
29. Probiotic alleviate fluoride-induced memory impairment by reconstructing gut microbiota in mice10.1016/j.ecoenv.2021.112108 ↗
30. Bacillus amyloliquefaciens TL106 protects mice against enterohaemorrhagic Escherichia coli O157:H7-induced intestinal disease through improving immune response, intestinal barrier function and gut microbiota10.1111/jam.14952 ↗
31. Orlando, A., Linsalata, M., Biano, G., Notarnicola, M., d’Attoma, B., Scavo, M.P., Tafaro, A., and Russo, F. (2018). Lactobacillus rhamnosus GG protects the epithelial barrier of Wistar rats from the pepsin-trypsin-digested gliadin (PTG)-induced enteropathy. Nutrients, 10.10.3390/nu10111698 ↗
32. The probiotic mixture IRT5 ameliorates age-dependent colitis in rats10.1016/j.intimp.2015.04.021 ↗
33. Synbiotic supplementation containing Bifidobacterium infantis and Xylooligosaccharides alleviates dextran sulfate sodium-induced ulcerative colitis10.1039/D0FO00518E ↗
34. Inhibition of Aeromonas hydrophila-induced intestinal inflammation and mucosal barrier function damage in crucian carp by oral administration of Lactococcus lactis10.1016/j.fsi.2018.09.041 ↗
35. Anti-colitis effect of Lactobacillus sakei K040706 via suppression of inflammatory responses in the dextran sulfate sodium-induced colitis mice model10.1016/j.jff.2016.12.045 ↗
36. Modulation of intestinal barrier function to ameliorate Salmonella infection in mice by oral administration of fermented milks produced with Lactobacillus plantarum MTCC 5690—A probiotic strain of Indian gut origin10.1099/jmm.0.000366 ↗
37. Homocysteine aggravates intestinal epithelial barrier dysfunction in rats with experimental uremia10.1159/000494018 ↗
38. Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis10.1152/ajpgi.90534.2008 ↗
39. Lactobacillus plantarum ZS2058 produces CLA to ameliorate DSS-induced acute colitis in mice10.1039/C5RA24491A ↗
40. Zhang, X., Tong, Y., Lyu, X., Wang, J., Wang, Y., and Yang, R. (2020, November 05). Prevention and Curation of DSS-Induced IBD in Mice with Bacillus Subtilis Fermented Milk via Inhibition of the Inflammatory Responses and Regulation of the Intestinal flora. PREPRINT (Version 1). Available online: https://www.semanticscholar.org/paper/Prevention-and-Curation-of-DSS-induced-IBD%C2%A0in-Mice-Zhang-Tong/5e21d04dcd3eed9f049c0fdf7c0d01397c7a6d0a.
41. Protective effect of biogenic polyphosphate nanoparticles from Synechococcus sp. PCC 7002 on dextran sodium sulphate-induced colitis in mice10.1039/C8FO01861H ↗
42. Cancer-protective effect of a synbiotic combination between Lactobacillus gasseri 505 and a Cudrania tricuspidata leaf extract on colitis associated colorectal cancer10.1080/19490976.2020.1785803 ↗
43. Mechanisms for Lactobacillus rhamnosus treatment of intestinal infection by drug-resistant Escherichia coli10.1039/D0FO00128G ↗
44. 2021. The roles of different Bacteroides fragilis strains in protecting against DSS-induced ulcerative colitis and related functional genes10.1039/D1FO00875G ↗
45. Antinociceptive effect of VSL#3 on visceral hypersensitivity in a rat model of irritable bowel syndrome: A possible action through nitric oxide pathway and enhance barrier function10.1007/s11010-011-1126-5 ↗
46. Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation10.4161/hv.28549 ↗
47. A novel postbiotic from Lactobacillus rhamnosus GG with a beneficial effect on intestinal barrier function10.3389/fmicb.2019.00477 ↗
48. Metabolic variability of a multispecies probiotic preparation impacts on the anti-inflammatory activity10.3389/fphar.2017.00505 ↗
49. The administration of Escherichia coli Nissle 1917 ameliorates development of DSS-induced colitis in mice10.3389/fphar.2018.00468 ↗
50. VSL#3 probiotics regulate the intestinal epithelial barrier in vivo and in vitro via the p38 and ERK signaling pathways
51. Esposito, G., Pesce, M., Seguella, L., Lu, J., Corpetti, C., del Re, A., de Palma, F.D.E., Esposito, G., Sanseverino, W., and Sarnelli, G. (2021). Engineered Lactobacillus paracasei producing palmitoylethanolamide (PEA) prevents colitis in mice. Int. J. Mol. Sci., 22.10.3390/ijms22062945 ↗
52. Intestinal anti-inflammatory effects of outer membrane vesicles from Escherichia coli Nissle 1917 in DSS-experimental colitis in mice10.3389/fmicb.2017.01274 ↗
53. Homeostasis effects of fermented Maillard reaction products by Lactobacillus gasseri 4M13 in dextran sulfate sodium-induced colitis mice10.1002/jsfa.11374 ↗
54. Tulyeu, J., Kumagai, H., Jimbo, E., Watanabe, S., Yokoyama, K., Cui, L., Osaka, H., Mieno, M., and Yamagata, T. (2019). Probiotics prevents sensitization to oral antigen and subsequent increases in intestinal tight junction permeability in juvenile–young adult rats. Microorganisms, 7.10.3390/microorganisms7100463 ↗
55. Yeo, S., Park, H., Seo, E., Kim, J., Kim, B.K., Choi, I.S., and Huh, C.S. (2020). Anti-inflammatory and gut microbiota modulatory effect of Lactobacillus rhamnosus strain LDTM 7511 in a dextran sulfate sodium-induced colitis murine model. Microorganisms, 8.10.3390/microorganisms8060845 ↗
56. Differential intestinal anti-inflammatory effects of Lactobacillus ermentum and Lactobacillus salivariusin DSS mouse colitis: Impact on micro RNAs expression and microbiota composition10.1002/mnfr.201700144 ↗
57. fermentum CECT 5716 prevents stress-induced intestinal barrier dysfunction in newborn rats10.1111/nmo.13069 ↗
58. Ukena, S.N., Singh, A., Dringenverg, U., Engelhardt, R., Seidler, U., Hansen, W., Bleich, A., Bruder, D., Franzke, A., and Rogler, G. (2007). Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS ONE, 2.10.1371/journal.pone.0001308 ↗
59. Lactobacillus plantarum restores intestinal permeability disrupted by salmonella infection in newly hatched chicks10.1038/s41598-018-20752-z ↗
60. Lactobacillus acidophilus alleviates pouchitis after ileal pouch-anal anastomosis in rats10.3748/wjg.v23.i26.4735 ↗
61. Effects of Lactobacillus plantarum on gut barrier function in experimental obstructive jaundice10.3748/wjg.v18.i30.3977 ↗
62. Zakostelska, Z., Kverka, M., Klimesova, K., Rossmann, P., Mrazek, J., Kopecny, J., Hornova, M., Srutkova, D., Hudcovic, T., and Ridl, J. (2011). Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment. PLoS ONE, 6.10.1371/journal.pone.0027961 ↗
63. Bifidobacterium longum and VSL#3® amelioration of TNBS-induced colitis associated with reduced HMGB1 and epithelial barrier impairment10.1016/j.dci.2018.09.006 ↗
64. Lactobacillus casei ATCC 393 alleviates enterotoxigenic Escherichia coli K88-induced intestinal barrier dysfunction via TLRs/mast cells pathway10.1016/j.lfs.2020.117281 ↗
65. Administration of Lactobacillus paracasei strains improves immunomodulation and changes the composition of gut microbiota leading to improvement of colitis in mice10.1016/j.jff.2018.11.035 ↗
66. Administration of commensal Shewanella sp. MR-7 ameliorates lipopolysaccharide-induced intestine dysfunction in turbot (Scophthalmus maximus L.)10.1016/j.fsi.2020.04.068 ↗
67. Lactobacillus rhamnosus EM1107 in goat milk matrix modulates intestinal inflammation involving NF-κB p65 and SOCs-1 in an acid-induced colitis model10.1016/j.jff.2018.09.013 ↗
68. Bacillus subtilis HH2 ameliorates TNBS-induced colitis by modulating gut microbiota composition and improving intestinal barrier function in rabbit model10.1016/j.jff.2020.104167 ↗
69. An engineering probiotic producing defensin-5 ameliorating dextran sodium sulfate-induced mice colitis via inhibiting NF-kB pathway10.1186/s12967-020-02272-5 ↗
70. Rothstein, H.R., Sutton, A.J., and Borenstein, M. (2005). The funnel plot. Publication Bias in Meta-Analysis: Prevention, Assessment and Adjustments, Wiley.10.1002/0470870168 ↗
71. Global signatures of protein and mRNA expression levels
72. Inhibitory Effect of Bifidobacterium Bifidum ATCC 29521 on colitis and its mechanism10.1016/j.jnutbio.2020.108353 ↗
73. Strengthening of the intestinal epithelial tight junction by Bifidobacterium bifidum10.14814/phy2.12327 ↗
74. Alterations in intestinal permeability10.1136/gut.2005.085373 ↗
75. Intestinal barrier function: Molecular regulation and disease pathogenesis10.1016/j.jaci.2009.05.038 ↗
76. The protective effect of VSL#3 on intestinal permeability in a rat model of alcoholic intestinal injury10.1186/1471-230X-13-151 ↗
77. Elimination diet and intestinal permeability in atopic eczema: A preliminary study10.1111/j.1365-2222.1993.tb02480.x ↗
78. The intestinal permeability test applied to the diagnosis of food allergy in pediatrics
79. Anti-inflammatory effects of rebaudioside A in LPS stimulated RAW264.7 macrophage cells
80. Is Lactobacillus GG helpful in children with Crohn’s disease? Results of a preliminary, open-label study
81. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier10.1152/ajpgi.00327.2009 ↗
82. Guidelines for the management of inflammatory bowel disease in adults10.1136/gut.2010.224154 ↗
83. Randomized, controlled trial evaluating the effect of multi-strain probiotic on the mucosal microbiota in canine idiopathic inflammatory bowel disease10.1080/19490976.2017.1334754 ↗
84. Analysis of data from multiclinic trials10.1016/0197-2456(86)90034-6 ↗
85. Measuring inconsistency in meta-analyses10.1136/bmj.327.7414.557 ↗
86. Research techniques made simple: Assessing risk of bias in systematic reviews10.1016/j.jid.2016.08.021 ↗
87. The meta-analysis10.4078/jrd.2015.22.1.4 ↗
88. Hedges, L.V., and Valentine, J.C. (2009). Publication bias. The Hand Book of Research Synthesis and Meta-Analysis, Russell Sage Foundation.
89. Celentano, D.D., and Szklo, M. (2019). Epidemiology and Public Policy. Gordis Epidemiology, Elesvier. [6th ed.].
90. The trim-and-fill method for publication bias: Practical guidelines and recommendations based on a large database of meta-analyses